Urogen Pharma Ltd Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Urogen Pharma Ltd 's inventory turnover ratio sequentially decreased to 1.54 in the second quarter 2026, unsurprisingly, as the Urogen Pharma Ltd markets continue to deteriorate, and URGN's faces growing challenges to bring down its inventories. Urogen Pharma Ltd 's average inventory processing period in the Jun 30 2026 quarter, has increased to 237 days, from 153 days, in the Mar 31 2026 quarter.

Within Healthcare sector 255 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1257 in the first quarter 2026, to 1443.

URGN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Urogen Pharma Ltd Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

URGN Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	545.89 %	216.48 %	19.9 %	22.17 %	-3.86 %
Y / Y Cost of Sales Growth	85.13 %	77.64 %	33.1 %	33.63 %	59.26 %
Inventory Turnover Ratio (TTM)	1.54	2.38	3.05	3.01	2.92
URGN's Total Ranking	# 1443	# 1257	# 1420	# 1101	# 1105
Average inventory processing period	236	153	120	121	125
Seq. Inventory Growth	120.35 %	105.81 %	51.37 %	-5.91 %	7.97 %
Seq. Cost of Sales Growth	58.78 %	25.84 %	0.34 %	-7.66 %	52.36 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 68
Healthcare Sector	# 256
Overall Market	# 1443

Inventory Turnover Ratio Statistics
High	Average	Low
4.25	3.13	1.54
(Sep 30 2023)		(Jun 30 2026)

URGN Company Profile >> Back to URGN Efficiency Comparisons >> Compare URGN Inventory Turnover Ratio to its Competitors

Financial Statements
Urogen Pharma Ltd 's Inventories	$ 25 Millions	Visit URGN's Balance sheet
Urogen Pharma Ltd 's Cost of Revenues TTM	$ 17 Millions	Visit URGN's Income Statement
What are URGN's Sales?		Visit URGN's Sales by Segment

Other Inventory Turnover Ratios
Urogen Pharma Ltd 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
URGN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for URGN's Competitors
Inventory Turnover Ratio for URGN's Suppliers
Inventory Turnover Ratio for URGN's Customers

You may also want to know
URGN's Sales Growth Rates	URGN's Pe Price to earnings ratio	URGN's Receivables Turnover Ratio	URGN's Stock Quote
URGN's Net Income Growth Rates	URGN's Ps Price to Sales ratio	URGN's Sales per Employee	URGN's Asset Turnover Ratio
URGN's Net Margin	URGN's Pb Price to Book ratio	URGN's Financial Strength Ratios	URGN's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Nature s Sunshine Products inc	1.92	$ 131.811 Millions	$ 69 Millions
Insulet Corporation	1.91	$ 883.000 Millions	$ 462 Millions
Innoviva Inc	1.91	$ 74.000 Millions	$ 39 Millions
Cytek Biosciences Inc	1.90	$ 96.247 Millions	$ 51 Millions
Immucell Corporation	1.89	$ 17.409 Millions	$ 9 Millions
Pacific Biosciences Of California Inc	1.89	$ 101.369 Millions	$ 54 Millions
Safe Pro Group Inc	1.88	$ 1.089 Millions	$ 1 Millions
Rigel Pharmaceuticals Inc	1.88	$ 23.839 Millions	$ 13 Millions
Sunshine Biopharma Inc	1.87	$ 24.637 Millions	$ 13 Millions
Amgen Inc	1.86	$ 11,613.000 Millions	$ 6,244 Millions
Ocular Therapeutix Inc	1.84	$ 6.708 Millions	$ 4 Millions
Trisalus Life Sciences Inc	1.82	$ 6.508 Millions	$ 4 Millions
Halozyme Therapeutics Inc	1.79	$ 292.421 Millions	$ 164 Millions
Seastar Medical Holding Corp	1.78	$ 0.126 Millions	$ 0 Millions
Alpha Pro Tech Ltd	1.76	$ 38.696 Millions	$ 22 Millions
Tenet Healthcare Corp	1.76	$ 605.000 Millions	$ 344 Millions
Tenon Medical Inc	1.76	$ 1.763 Millions	$ 1 Millions
Iradimed Corporation	1.76	$ 20.839 Millions	$ 12 Millions
Utah Medical Products Inc	1.75	$ 14.771 Millions	$ 8 Millions
Elutia Inc	1.75	$ 4.337 Millions	$ 2 Millions
Axsome Therapeutics Inc	1.73	$ 52.530 Millions	$ 30 Millions
Vycor Medical Inc	1.72	$ 0.301 Millions	$ 0 Millions
Harvard Bioscience Inc	1.71	$ 37.097 Millions	$ 22 Millions
Quanterix Corporation	1.69	$ 87.760 Millions	$ 52 Millions
Haemonetics Corporation	1.68	$ 553.577 Millions	$ 329 Millions
Conmed Corporation	1.68	$ 606.349 Millions	$ 362 Millions
Stryker Corp	1.67	$ 9,049.000 Millions	$ 5,405 Millions
Atricure Inc	1.67	$ 134.975 Millions	$ 81 Millions
Ceribell Inc	1.66	$ 11.159 Millions	$ 7 Millions
The Cooper Companies Inc	1.65	$ 1,443.300 Millions	$ 875 Millions

Date modified: 2026-09-09T22:40:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.